ImmuCell CorporationICCCNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR-13.3%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-13.3%/yr
vs +24.9%/yr prior
Acceleration
-38.2pp
Decelerating
Percentile
P86
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 18.85% |
| 2024 | 8.81% |
| 2023 | -4.24% |
| 2022 | 28.93% |
| 2021 | 8.78% |
| 2020 | -2.93% |
| 2019 | 4.76% |
| 2018 | 11.89% |
| 2017 | 4.00% |
| 2016 | 13.58% |